These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 33455846

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Implication of Different ECG Left Ventricular Hypertrophy in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Yang Y, Ahn JM, Kang DY, Ko E, Kim S, Kim TO, Kim JH, Lee J, Lee SA, Kim DH, Kim HJ, Kim JB, Choo SJ, Park SJ, Park DW.
    J Am Heart Assoc; 2022 Feb 15; 11(4):e023647. PubMed ID: 35112886
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical value of regression of electrocardiographic left ventricular hypertrophy after aortic valve replacement.
    Yamabe S, Dohi Y, Higashi A, Kinoshita H, Sada Y, Hidaka T, Kurisu S, Shiode N, Kihara Y, HERO (Hiroshima Heart Study Group) Investigators.
    Heart Vessels; 2016 Sep 15; 31(9):1497-503. PubMed ID: 26531830
    [Abstract] [Full Text] [Related]

  • 5. Absence of electrocardiographic left ventricular hypertrophy is associated with increased mortality after transcatheter aortic valve replacement.
    Kampaktsis PN, Ullal AV, Swaminathan RV, Minutello RM, Kim L, Bergman GS, Feldman DN, Singh H, Wong SC, Okin PM.
    Clin Cardiol; 2018 Sep 15; 41(9):1246-1251. PubMed ID: 30062778
    [Abstract] [Full Text] [Related]

  • 6. Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Varshney AS, Manandhar P, Vemulapalli S, Kirtane AJ, Mathew V, Shah B, Lowenstern A, Kosinski AS, Kaneko T, Thourani VH, Bhatt DL.
    JACC Cardiovasc Interv; 2019 Feb 25; 12(4):373-382. PubMed ID: 30784643
    [Abstract] [Full Text] [Related]

  • 7. Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy After Transcatheter Aortic Valve Implantation: Insights from the OCEAN-TAVI Registry.
    Koga M, Izumo M, Yoneyama K, Akashi YJ, Yashima F, Tada N, Yamawaki M, Shirai S, Naganuma T, Yamanaka F, Ueno H, Tabata M, Mizutani K, Takagi K, Watanabe Y, Yamamoto M, Hayashida K, OCEAN-TAVI Investigators.
    Am J Cardiol; 2023 Oct 01; 204():130-139. PubMed ID: 37541149
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic impact of left ventricular mass regression after transcatheter aortic valve replacement in patients with left ventricular hypertrophy.
    Oh JK, Lee SH, Lee SA, Kang DY, Lee S, Kim HJ, Ahn JM, Kim JB, Park DW, Song JM, Choo SJ, Kang DH, Song JK, Park SJ, Kim DH.
    Int J Cardiol; 2021 Jun 01; 332():60-66. PubMed ID: 33781852
    [Abstract] [Full Text] [Related]

  • 14. Regression of Electrocardiographic Left Ventricular Hypertrophy After Transcatheter Aortic Valve Implantation for Aortic Stenosis.
    Tobe A, Tanaka A, Tokuda Y, Akita S, Fujii T, Miki Y, Furusawa K, Ishii H, Usui A, Murohara T.
    Circ J; 2021 Jun 25; 85(7):1093-1098. PubMed ID: 34039838
    [Abstract] [Full Text] [Related]

  • 15. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM, Boman K, Gohlke-Baerwolf C, Kesäniemi YA, Nienaber C, Ray S, Egstrup K, Rossebø AB, Devereux RB, Køber L, Willenheimer R, Wachtell K.
    Circulation; 2012 Jan 17; 125(2):346-53. PubMed ID: 22147903
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN, Devereux RB, Okin PM.
    J Electrocardiol; 2014 Jan 17; 47(5):630-5. PubMed ID: 25052475
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of transcatheter aortic valve replacement on left ventricular hypertrophy, diastolic dysfunction and quality of life in patients with preserved left ventricular function.
    Dahiya G, Kyvernitakis A, Joshi AA, Lasorda DM, Bailey SH, Raina A, Biederman RWW, Kanwar MK.
    Int J Cardiovasc Imaging; 2021 Feb 17; 37(2):485-492. PubMed ID: 32902782
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.